Isotope labelled Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector. Molecular Formula: C20H15D4F2N3O5 Solubility: DMSO (Slightly), Methanol (Slightly) Molecular Weight: 423.4 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
423.4
Form:
Supplied as a Off-White to Pale Beige Solid
* VAT and and shipping costs not included. Errors and price changes excepted
